Veriheal

JULY 16, 2020

Despite the novelty of its drug policy findings, the document has gone largely unnoticed by reform advocates and the media. The panel, led by Jake Leinenkugel (a presidential nominee), asserted that psychedelics, such as MDMA and psilocybin, as well as cannabis, present promising ways to treat mental health conditions among military veterans.

Research and Development 97

Research and Development Clinical Trials Treatment Compliance 97

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Events 40

Project CBD

AUGUST 6, 2019

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Veriheal

MAY 3, 2022

The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. Clinical Trial Sample Size. a necessary question to address as medical marijuana becomes more accessible. Daily Cannabis Use as a Disqualifier. Various Limitations.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

AUGUST 25, 2021

“Lucid has successfully developed a strong pipeline of novel therapeutic compounds — supported by IP in order to advance to future clinical trials — and we are confident that the experience the Lucid leadership team brings will allow us to immediately start the process towards clinical trials to further advance these promising therapies.

Clinical Trials 85

Clinical Trials Research and Development Therapy Conditions 85

MMJ Recs

JULY 9, 2024

Living with chronic conditions such as Multiple Sclerosis (MS) is profoundly challenging and impacts various aspects of daily life. of medical marijuana as a viable treatment option for certain conditions, including Multiple Sclerosis (MS), leading to increased advocacy for uniform regulations and broader accessibility.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

CannaMD

MAY 25, 2021

A recent study documented bone healing in rodents with broken femoral bones, in which subjects were injected with a formula of either THC or CBD. Multiple experimental and clinical trials have portrayed CBD as a safe agent, suggesting further studies in humans to assess its usefulness for improving fracture healing.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

Cannabis Law Report

JUNE 19, 2022

For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art. However, that does not mean that the path to patents is closed off.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. The respondents ranged in age from 19 to 81, and 50% identified as White, 20% as Latino, 12% as Asian, and 10% as Black.

Education 103

Education Clinical Trials Medicine Policy 103

Veriheal

JUNE 7, 2021

It turns out that this blissful drug, MDMA, has the potential to be used effectively as a treatment for certain conditions- some of which are in urgent need of effective medical assistance. . MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . What is MDMA?

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Ensure high quality, timely, and consistent submission of regulatory documents. European Regulatory Lead Executive Summary.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Weedistry

FEBRUARY 4, 2019

Currently, 33 states along with the District of Columbia, Guam and Puerto Rico have passed laws for comprehensive medical cannabis programs — but critics often point out we’re lacking definitive proof that marijuana safely and effectively treats many of the qualifying conditions. There are two things wrong with this argument.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

JULY 28, 2021

We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Glaucoma is still the first condition many people think of when they consider cannabis as a medicine. CBD and Immunosuppressant Medications. CBD and Glaucoma.

CBD 98

CBD THC Conditions Medicine 98

CannaMD

AUGUST 26, 2020

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Conditioned place preference. mice/rats). The studies were then broken into eight categories: Cocaine self-administration. Brain-stimulation reward. Hepatic protection.

Therapy 98

Therapy CBD Research and Development Treatment 98

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming.

History 123

History Microdosing Research and Development Clinical Trials 123

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52

Law Clinical Trials Dispensary Programs 52

SpeedWeed

AUGUST 16, 2021

Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of ??5-MeO-DMT 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), a powerful compound produced endogenously by Sonoran Desert toad venom, to treat depression. .

Research and Development 52

Research and Development Clinical Trials Treatment Conditions 52

The Cannigma

JULY 1, 2022

Observational studies involve watching the subject and documenting outcomes like a reporter, whereas in interventional studies the researchers take a specific action and monitor the response. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 112

Research and Development Data THC Clinical Trials 112

MMJ Recs

MAY 9, 2024

Many veterans struggle with various physical and psychological conditions resulting from their service. These professionals can provide valuable insights into whether medical cannabis is a suitable option based on the veteran’s medical history, current conditions, and treatment goals.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

CannaMD

MARCH 8, 2021

Which begs the question: Why is it okay for Big Pharma to profit from high-potency THC drugs, while Florida patients can’t use high-potency THC medical marijuana to treat documented health conditions under a physician’s care? Cesamet, like dronabinol-containing products, is indicated for nausea associated with cancer chemotherapy.

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

MMJ Recs

APRIL 10, 2021

The vaccine was designed to protect people from the coronavirus and went through extensive clinical trials to test its safety. In many states, individuals with a variety of serious conditions are now eligible for vaccines (including folks with diabetes, lung conditions, cancer, etc.)

Clinical Trials 52

Clinical Trials Safety Patients Tincture 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Glaucoma is still the first condition many people think of when they consider cannabis as a medicine. CBD and Immunosuppressant Medications. CBD and Glaucoma.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

JANUARY 11, 2019

However, we firmly disagree that the referenced clinical trials are in fact “substantial,” as the trials were extremely limited in scope, and funding and the publication of these trials were limited.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. That is a medical condition. But the doctor isn’t giving the patient any guidance. But what do we do in the meantime?

Legalization 130

Legalization Patients Education Dispensary 130

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 40

Therapy Research and Development Business Access 40

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana, through its appetite-stimulating effects (often referred to as “the munchies”), can combat this condition.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

DECEMBER 7, 2021

Since 2017, several clinical trials and observational studies have examined the efficacy of MCs in the pediatric population for a few indications, most of them focused on CBD efficacy in Dravet syndrome 28 , 29 , 30. A reason for exclusion for every individual study was documented. Disagreements were resolved by discussion.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.

Medicine 52

Medicine Therapy Research and Development Business 52

CannaMD

MARCH 8, 2020

Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. population, has an arrhythmia.

Patients 80

Patients Marijuana Research and Development Clinical Trials 80

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. to take a medical marijuana course that reviews the endocannabinoid system and the therapeutic use of marijuana.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52